Literature DB >> 10506391

[Reopening of a persistent left superior vena cava in the early postoperative period following bidirectional cavopulmonary anastomosis--treatment by coil embolization].

I Michel-Behnke1, H Akintürk, D Schranz.   

Abstract

Diagnosis of systemic venous drainage is mandatory for patients with congenital heart disease planned for cavopulmonary anastomosis or any Fontan-type palliation. Preexisting venous channels as the persistent left superior vena cava are common in cardiac anomalies and may lead to postoperative deterioration and cyanosis. We describe a 6 month old boy with a complex imbalanced atrioventricular septal defect who developed cyanosis in the very early postoperative period, following bidirectional cavopulmonary anastomosis. It was caused by ineffective lung perfusion due to a reopened persistent left superior vena cava with drainage to the coronary sinus.He underwent coil embolization of the persistent left superior vena cava with retrievable coils and cyanosis improved. Coil embolization is an effective alternative to secondary surgery, especially for hemodynamically compromised patients in the postoperative period.

Entities:  

Mesh:

Year:  1999        PMID: 10506391     DOI: 10.1007/s003920050325

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  3 in total

1.  Recanalisation of bilateral superior vena cava after total cavopulmonary connection. Interventional occlusion with the Amplatzer VSD Occluder.

Authors:  M Girisch; L Sieverding; R Rauch; R Kaulitz; M Gass; G Ziemer; M Hofbeck
Journal:  Z Kardiol       Date:  2005-07

2.  Fenestration in extracardiac conduits in children after modified Fontan operation by implantation of stent grafts.

Authors:  I Michel-Behnke; M Luedemann; J Bauer; K-J Hagel; H Akintuerk; D Schranz
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

Review 3.  Biocompatibility screening in cardiovascular implants.

Authors:  M Sigler; T Paul; R G Grabitz
Journal:  Z Kardiol       Date:  2005-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.